Your institution may have access to this item. Find your institution then sign in to continue.
Title
Phase I studies of hypericin, the active compound in St. John's Wort, as an antiretroviral agent in HIV-infected adults. AIDS Clinical Trials Group Protocols 150 and 258.
Authors
Gulick, R M; McAuliffe, V; Holden-Wiltse, J; Crumpacker, C; Liebes, L; Stein, D S; Meehan, P; Hussey, S; Forcht, J; Valentine, F T
Abstract
Hypericin, the active compound in St. John's Wort, has antiretroviral activity in vitro. Many HIV-infected persons use St. John's wort.
Publication
Annals of internal medicine, 1999, Vol 130, Issue 6, p510